High Cholesterol Causes and Risk Factors

Patient Profile: Introducing Carlos

Carlos is a 52‑year‑old man who works as an accountant. He recently visited his primary care physician after noticing intermittent fatigue and a mild shortness of breath on exertion. A fasting lipid panel showed an LDL cholesterol of 160 mg/dL, triglycerides of 210 mg/dL, and HDL of 38 mg/dL. His doctor explained that these values fall above the desirable ranges and asked Carlos to review his lifestyle and family history.

Cholesterol is a waxy substance essential for building cell membranes, producing hormones, and synthesizing vitamin D. It travels in the bloodstream attached to lipoproteins; low‑density lipoprotein (LDL) carries cholesterol to tissues, while high‑density lipoprotein (HDL) returns excess cholesterol to the liver for removal. When LDL particles linger in the blood, they can infiltrate artery walls, initiate inflammation, and contribute to the formation of atherosclerotic plaque.

To understand why Carlos’s numbers are elevated, we will walk through the most common contributors: genetic makeup, dietary choices, physical activity level, existing health conditions, and demographic factors such as age and sex. Each of these elements can independently raise LDL, triglycerides, or lower HDL, and together they often produce the pattern seen in his lipid panel.

Genetic Influences and Family History

Carlos reports that his father suffered a heart attack at age 58 and has been on a statin for elevated cholesterol since his early fifties. His mother also takes a lipid‑lowering medication. This family pattern suggests a hereditary component that may be influencing Carlos’s own lipid metabolism. Such a history raises the likelihood of genetic variants that affect LDL clearance.

Variations in genes such as LDLR, APOB, or PCSK9 can reduce the number or function of LDL receptors on liver cells, slowing the removal of LDL from circulation. In addition, many common genetic variants each contribute a small effect; when combined in a polygenic risk score they can substantially increase susceptibility to high LDL.

If Carlos pursued genetic testing, a heterozygous LDLR mutation was identified, which typically cuts LDL receptor activity by about half. This defect alone can raise LDL cholesterol by 30‑50 mg/dL, accounting for a significant portion of his measured 160 mg/dL level. Such a finding would also explain why his family members have similar lipid abnormalities.

Dietary Patterns That Raise Lipids

Carlos’s morning routine often starts with two slices of white toast spread with butter, a couple of sausage links, and a glass of orange juice. For lunch he frequently orders a pizza slice with extra cheese or a fried‑chicken sandwich, accompanied by a sugary soda. Dinner commonly features a grilled steak topped with a cream‑based sauce, served with white rice or mashed potatoes, and he finishes with cookies or ice cream.

Saturated fats, abundant in butter, fatty cuts of meat, and full‑fat dairy, stimulate the liver to produce more LDL particles. Trans fats, often found in processed snacks and baked goods, not only raise LDL but also lower HDL, worsening the lipid profile. Refined carbohydrates, such as white bread and sugary drinks, are rapidly converted to glucose; excess glucose triggers hepatic de novo lipogenesis, increasing triglyceride synthesis.

Estimating his intake, Carlos consumes roughly 38 % of total calories from fat, with about 14 % coming from saturated fat—well above the <10 % target. Carbohydrates supply approximately 55 % of his energy, a large share from refined sources. This macronutrient pattern aligns with the elevated LDL and triglyceride values observed in his lab results.

Physical Inactivity, Weight, and Metabolic Effects

Carlos spends most of his workday seated at a desk, takes elevators instead of stairs, and logs fewer than 2,000 steps daily. He reports no regular aerobic or resistance training. His weight is 92 kg, giving a body mass index of 31 kg/m², and his waist circumference measures 102 cm. His sedentary routine also limits opportunities for stress‑relieving activities such as walking or stretching, which can indirectly affect lipid metabolism through hormonal pathways.

Physical inactivity reduces the activity of lipoprotein lipase in skeletal muscle, the enzyme that clears triglycerides from the bloodstream. Simultaneously, excess adipose tissue, especially visceral fat, releases free fatty acids that travel to the liver and stimulate the production of very‑low‑density lipoprotein (VLDL), which carries triglycerides and can be converted to LDL.

Research shows that each 5‑unit increase in BMI is associated with an approximate rise of 5 mg/dL in LDL and 10‑15 mg/dL in triglycerides. For Carlos, whose BMI is 31, these mechanisms likely contribute several milligrams per deciliter to his elevated lipid levels.

Medical Conditions That Exacerbate Cholesterol

Two years ago Carlos was diagnosed with hypertension; his blood pressure averages 148/92 mm Hg despite taking a thiazide diuretic. Recent screening also revealed a fasting glucose of 110 mg/dL, placing him in the pre‑diabetes range. Both conditions are components of metabolic syndrome, a cluster that often accompanies dyslipidemia.

Insulin resistance, a hallmark of pre‑diabetes, leads to higher hepatic VLDL output and reduced LDL receptor activity, thereby raising triglycerides and LDL. Hypertension can damage the endothelium, making arterial walls more prone to LDL retention and inflammatory changes. These processes together exacerbate the atherogenic lipid profile seen in Carlos.

Certain medications used to treat blood pressure, including thiazides and beta‑blockers, have been associated with modest increases in LDL or triglycerides in some individuals. However, the primary driver of Carlos’s lipid abnormality is the combination of insulin resistance, excess weight, and genetic predisposition rather than the drugs themselves.

Age, Sex, and Hormonal Factors

As men age, hepatic LDL receptor activity tends to decline, and cholesterol synthesis may shift slightly toward greater LDL production. At 52, Carlos is within the age range where these physiological changes begin to noticeably affect lipid levels. This age‑related decline contributes to the upward trend in LDL observed across middle‑aged populations.

Sex hormones also influence lipid metabolism. Pre‑menopausal women generally have higher HDL and lower LDL than men of the same age, partly due to estrogen’s up‑regulation of LDL receptors. After menopause, women's lipid patterns converge with those of men, eliminating this protective difference.

Lower testosterone levels with advancing age can favor the accumulation of visceral fat, which, as discussed, drives hepatic VLDL secretion and raises triglycerides. Consequently, Carlos’s male sex and age together create a backdrop that amplifies the impact of his diet, inactivity, and genetic risk.